AG00ICN3

755037-03-7 | 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-

Chemical structure of 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, CAS 755037-03-7
AG00ICN3
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 755037-03-7
Catalog Number AG00ICN3(AGN-PC-0U7EL8)
Chemical Name 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
IUPAC Name 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
InChI InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)
InChI Key FNHKPVJBJVTLMP-UHFFFAOYSA-N
MDL Number MFCD17170366
Molecular Formula C21H15ClF4N4O3
Molecular Weight 482.8154
SMILES O=C(NC)C1=NC=CC(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C(F)=C2)=C1
UNII 24T2A1DOYB
Synonyms
4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-n-methylpyridine-2-carboxamide, BAY 73-4506, BAY-73-4506, BAY73-4506, regorafenib, Stivarga, Regorafenib, 755037-03-7, BAY 73-4506, Stivarga, Regorafenibum, 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide, Regorafenib (BAY 73-4506), BAY73-4506, UNII-24T2A1DOYB, BAY-73-4506, 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide, 24T2A1DOYB, CHEMBL1946170, CHEBI:68647, Stivarga (TN), BAY73-4506 hydrochloride, 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide, Regorafenib [USAN:INN], Fluoro-Sorafenib, 4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl}amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide, Regorafenib (USAN/INN), RegorafenibBAY73-4506, BAY-734506 monohydrate, MLS006010303, C21H15ClF4N4O3, SCHEMBL432230, Regorafenib,BAY 73-4506, GTPL5891, QCR-85, BAY73-4506(Regorafenib)/, Regorafenib(BAY 73-4506), DTXSID60226441, EX-A058, Regorafenib - BAY 73-4506, SYN1169, FNHKPVJBJVTLMP-UHFFFAOYSA-N, BCPP000352, HMS3654K16, Regorafenib, 755037-03-7, AOB87754, BCP02105, KS-00000Q4Q, ZINC6745272, ABP000611, BDBM50363397, MFCD16038047, s1178, AKOS015951107, ACN-036634, AM81251, BAY 734506, BCP9000384, CS-0170, DB08896, RL04875, SB16819, NCGC00263138-01, NCGC00263138-13, 4CA-1083, AC-25075, AJ-56815, AK106990, AS-16304, CJ-13100, HY-10331, SC-28977, SMR004701370, AB0008044, AB1008457, AX8232295, FT-0674338, R0142, ST24023156, SW218097-2, cas:835621-07-3;Regorafenib hydrochloride, Regorafenib (BAY73-4506 Fluoro-Sorafenib), A25020, D10138, S-7780, AB01565826_02, SR-01000941571, SR-01000941571-1, BRD-K16730910-001-02-4, 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluoro-phenoxy]-N-methyl-pyridine-2-carboxamide, 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carbox, 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide, 835621-08-4, Regorafenib;1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea, Regorafenib hydrate, anhydrous regorafenib, Regorafenib [INN], DAST, regorafenib monohydrate, D09GDD, cc-195, Regorafenib(BAY73-4506), Regorafenib, 98% - 10MG 10mg, AN-1324, CS-T-41574, CID11167602, CID 11167602, A8236, A10250, C559147, 4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-n-methylpyridine-2-carboxamide, 4-(4-(2-(4-Chloro-3-(trifluoromethyl)phenylamino)-2-oxoethyl)-3-fluorophenoxy)-N-methylpicolinamide,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited